AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2012
Sep 18, 2012
32134_dirs_2012-09-18_97d1614c-39e4-4015-a7e2-b4913d4b6064.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2012-09-14
Reporting Person: Lingnau Lutz (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-14 | Stock Option | $9.24 | A | 40000 | Acquired | 2020-09-13 | Common Stock (40000) | Direct |
Footnotes
F1: This stock option vests in equal monthly installments over a 1 year period beginning on September 30, 2012 based on the Reporting Person's continuous service to the Issuer.
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20